Loading market data...
Latest Top News
Show more
Dr. Reddy’s Srikakulam Facility Secures Positive USFDA VAI Outcome
Dr. Reddy’s Laboratories has announced that the USFDA classified its recent inspection at the Srikakulam facility as Voluntary Action Indicated (VAI). Covering GMP and pre-approval processes, the inspection has been officially closed. The company received the Establishment Inspection Report (EIR) on March 4, 2026, reinforcing regulatory compliance and operational credibility.
Stay Ahead – Explore Now! HLE Glascoat’s Subsidiary Acquires Omeras GmbH Assets for Euro 2.75 Million, Bolstering Global Glass-Lined Solutions Portfolio






